← brief for 2026-09-28 · Slowing decline

Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study.

Key takeaways

This small test looked at a diabetes drug called empagliflozin. It was given to people with liver disease and fluid buildup in the belly. The drug helped the body shed salt through the urine. The study was short, lasting only 10 days. It shows the drug works, but it is not a long-term cure.

Who did this work

Shi R · Gao Y · Gao Y · Zhou L · Qin W · Zhao F · Jia J · Hu Z

Source

Article · PubMed, the drug frontier · 2026 Sep 26
https://pubmed.ncbi.nlm.nih.gov/42803247/